Episode 7: The First Uromigos Prostate Cancer...

Tanya Dorff joins Tom and Brian to discuss her ASCO 2026 data on a novel dual targeting ADC in prostate cancer. The broader scope of ADC development in prostate cancer is discussed with a focus on cytopenia toxicity and future direcctions. 

This comprehensive podcast covers the latest advances in prostate, bladder, and kidney cancers from ASCO 2026, including new therapies, trial data, and practice-changing insights. Brian, Tom and Silke analyze recent studies, controversies, and future directions in GU oncology. 

In this episode, Dr Keith Rourke discusses the diagnosis and management of prostate cancer. After listening to this podcast, learners will be able to: discuss early detection of prostate cancer explain what PSA is list the treatment options for prostate cancer in its early and ad ...  Show more

Kenny joins Gabby on the anniversary of his Prostatectomy to talk about how the diagnosis affected him and the changes his body has gone through in the year since his operation. It’s also a frank and honest chat about how the couple have navigated this together – and yes, ther ...

In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ...  Show more

Mark Lewis was inspired to become a cancer doctor after living through the highs and lows of his father’s cancer journey. On day one of his oncology fellowship, Mark developed an abdominal pain and was suddenly diagnosed with the very same cancer that took his father; a cancer, h ...  Show more